ARC at Sheba Medical Center and Mount Sinai launch collaboration with NVIDIA to crack the hidden code of the human genome through AI
Business Announcement
Updates every hour. Last Updated: 18-Nov-2025 05:11 ET (18-Nov-2025 10:11 GMT/UTC)
ARC Innovation at Sheba Medical Center and Icahn School of Medicine at Mount Sinai (part of the Mount Sinai Health System in New York City) today announced a landmark three-year collaboration with NVIDIA to harness the power of artificial intelligence for genomic discovery through the application of large language model (LLM) technology. The initiative aims to pioneer the decoding of the majority of the human genome that remains poorly understood in order to unlock new pathways for disease prevention, diagnosis, and treatment. Over the three-year period, the project will be supported by significant investment from the participating organizations, with the goal of accelerating research that can ultimately benefit patients worldwide.
A research team has tested how well three large language models can detect overlaps and redundancies in clinical questionnaires on mental illness / publication in ‘Nature Mental Health’
Apriori Bio, a Flagship Pioneering portfolio company, and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) have announced a research collaboration to co-develop self-amplifying RNA (saRNA) vaccine candidates targeting H5 influenza. The partnership combines Apriori’s Octavia™ AI-guided antigen-design platform with A*STAR IDL’s saRNA delivery technology and infectious-disease expertise, advancing breakthrough solutions for the advancement of human health, supporting the development of next-generation vaccines and contributing to Singapore’s growth as a global hub for biomedical innovation.
Nearly half of U.S. adults (47%) are worried they won’t be able to afford necessary healthcare in the coming year, the highest level of concern recorded since West Health and Gallup began tracking in 2021. The share of Americans reporting that they or someone in their household were not able to pay for prescription medications in the past three months has reached a record high of 20%, or one in five Americans.